Metraipolis › archive › dc_61bfc4df41db

International real-world study on osilodrostat efficacy and safety in adrenal Cushing syndrome — Europe PMC PMID:41824768

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41824768
DOI: 10.1210/clinem/dgag115
License (as archived): solo-consultazione
Archived: 2026-10-18T14:08:44.142Z
SHA-256 of the archived text: 94fe5d5b960b1f3d120693a85e332169c37b918cc0156393213d21f4b469f74e
Stable URL of this page: https://metraipolis.com/documento/dc_61bfc4df41db

How to cite

International real-world study on osilodrostat efficacy and safety in adrenal Cushing syndrome — Europe PMC PMID:41824768 — Europe PMC (en), https://europepmc.org/article/MED/41824768 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_61bfc4df41db (Metraipolis archive dc_61bfc4df41db, sha256 94fe5d5b960b1f3d120693a85e332169c37b918cc0156393213d21f4b469f74e)

BibTeX

@misc{dc61bfc4df41db,
  title = {International real-world study on osilodrostat efficacy and safety in adrenal Cushing syndrome — Europe PMC PMID:41824768},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41824768},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_61bfc4df41db; sha256 94fe5d5b960b1f3d120693a85e332169c37b918cc0156393213d21f4b469f74e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41824768. Agents can read the archived copy with the MCP tool read_document.